Tensive
Manufacturing · Italy · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Via Timavo 34, Milano, Lombardy, 20124, ...Website
www.tensive.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Tensive
Tensive S.r.l. is a biomedical startup founded in 2012, focused on developing innovative bioresorbable scaffolds for natural breast reconstruction and augmentation. Their flagship product, REGENERA, aims to improve the quality of life for breast cancer survivors by providing a safe and effective solution for breast restoration after lumpectomy. The company is currently undergoing clinical investigations to bring its products to market, targeting patients who have undergone breast surgery. Tensive's mission is to enhance clinical outcomes and accessibility for women worldwide through advanced biomaterials technology.Explore more
Popular SearchesTensiveSIC Code 38,384NAICS Code 33,339Show moreTensive Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tensive your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Tensive has new funding data
Earning: See what the market has to say on Tensive recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Tensive
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Tensive has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Tensive, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Tensive is spiking on competitors!
Click to see if Tensive had a recent Job posting/layoffs
Product Launch: Get notified when Tensive launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Tensive is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tensive is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tensive.
Tensive financials insights
Gather financial insights about Tensive, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$560K
Tensive Tech Stack
A closer look at the technologies used by Tensive
Tensive News & Media
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
Tensive appoints serial medtech entrepreneur Peter Crosby Chairman as REGENERA™/SOFTAG™ breast reconstruction bioresorbable scaffold nears CE mark approvalTensive publishes positive interim pivotal clinical data showing REGENERA™ supports natural breast reconstruction in Updates in Surgery
Milan, Italy – April15, 2026 – Tensive S.r.l., a clinical-stage advanced biomaterials medical device company developing REGENERA™ bioresorbable scaffolds for breast reconstruction and tissue marking, today announced new data in a peer-reviewed article published in Updates in Surgery (UPIS). The paper reports preplanned interim results from the first 25 of 94 patients in Tensive’s ongoing pivotal trial (NCT05941299), who completed six months follow-up after breast-conserving surgery (BCS) and adjIndependent study presented at ECR highlights REGENERA™ bioresorbable scaffold potential for breast restoration after lumpectomy
Milan, Italy – March 04, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™ bioresorbable scaffolds for breast reconstruction and tissue marking, today announced that independent investigators from the University of Pisa and the AOUP Breast Center (Pisa University Hospital) presented new data at the European Congress of Radiology (ECR 2026) in Vienna, Austria.Tensive reports positive pivotal trial top-line results showing REGENERA™ bioresorbable device may transform breast reconstruction
Milan, Italy – January 8, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™/SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, today announced top-line results from a pivotal trial evaluating the REGENERA™ implant in patients undergoing lumpectomy to treat malignant lesions.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tensive
Sign Up For FreeTo access detailed company insights
Tensive S.r.l. is a biomedical startup founded in 2012, focused on developing innovative bioresorbable scaffolds for natural breast reconstruction and augmentation. Their flagship product, REGENERA, aims to improve the quality of life for breast cancer survivors by providing a safe and effective solution for breast restoration after lumpectomy. The... Read More
